Uliledlimab is a potent against CD73 humanized monoclonal antibody. Uliledlimab inhibits the conversion of extracellular adenosine monophosphate (AMP) to adenosine. Uliledlimab can be used in research of cancer.
Purity:
99.0%
CAS Number:
[2378407-27-1]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted